Our profiling and comparison of the steps of conolidine and cannabidiol with known pharmacological agents predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE. The atypical chemokine receptor ACKR3 has just lately been documented to act as an opioid scavenger with exclusive negative regulatory Attributes towards distinctive families https://williamu839oeu5.activablog.com/profile